Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cerilliant
Novartis
Mallinckrodt
Dow
Citi
Johnson and Johnson
US Army
Express Scripts
Boehringer Ingelheim

Generated: January 21, 2018

DrugPatentWatch Database Preview

Rizatriptan benzoate - Generic Drug Details

« Back to Dashboard

What are the generic sources for rizatriptan benzoate and what is the scope of rizatriptan benzoate freedom to operate?

Rizatriptan benzoate
is the generic ingredient in three branded drugs marketed by Merck, Apotex Inc, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Mylan Pharms Inc, Natco Pharma Ltd, Panacea Biotec Ltd, Sandoz, Unichem Labs Ltd, Alkem Labs Ltd, Cipla Ltd, Eci Pharms Llc, Emcure Pharms Ltd, Glenmark Generics, Invagen Pharms, and Teva Pharms, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for rizatriptan benzoate. Twenty-nine suppliers are listed for this compound.
Summary for rizatriptan benzoate

US Patents and Regulatory Information for rizatriptan benzoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 078739-001 Jul 1, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apotex Inc RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 202244-002 Dec 31, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Macleods Pharms Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 203146-002 Sep 19, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unichem Labs Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 207835-002 Mar 7, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unichem Labs Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 207836-002 Mar 7, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Generics RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 203334-001 Oct 16, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 202490-001 Dec 31, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck MAXALT-MLT rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 020865-001 Jun 29, 1998 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Panacea Biotec Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 204722-001 Jan 11, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jubilant Generics RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 203252-001 Dec 31, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for rizatriptan benzoate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck MAXALT-MLT rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 020865-001 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT-MLT rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 020865-002 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT-MLT rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 020865-001 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT-MLT rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 020865-002 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT rizatriptan benzoate TABLET;ORAL 020864-002 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT rizatriptan benzoate TABLET;ORAL 020864-001 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT-MLT rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 020865-002 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT rizatriptan benzoate TABLET;ORAL 020864-001 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT rizatriptan benzoate TABLET;ORAL 020864-002 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Merck MAXALT-MLT rizatriptan benzoate TABLET, ORALLY DISINTEGRATING;ORAL 020865-001 Jun 29, 1998 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
US Army
Mallinckrodt
Julphar
Merck
Harvard Business School
Farmers Insurance
Argus Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot